Register for all our upcoming webinars.

 

Healthcare & Life Sciences Supply Chain

The webinar series focuses on the trends, issues and opportunities along each stage of supply chain life cycle for healthcare and life sciences companies.

Please click the banner to learn more.

 

Australian Healthcare and Life Sciences 9th Annual Executives and Legal Counsel Webinar

The three-part webinar discusses legal updates on topical matters in the industry::

Session 1:
Access recording
Key patent developments impacting the healthcare and life sciences industry, Corporate governance update and Key Australian Government initiatives supporting the healthcare and life sciences industry and tax update.

Session 2:
Access recording
The realities of dealing with a whistleblowing report and The future of work post COVID - remote working and its risks.

Session 3:
Access recording
Competition law hot topics and Regulatory update.

Cannabis

Cannabis, Hemp and Psychedelics: The regulatory landscape across 100 jurisdictions
Access recording
The session presents a panoramic overview of the rules regulating cannabis across 100 markets through our unique and interactive global survey, which provides insight into the evolving state of cannabis and hemp laws across the world.

Import and Export of Cannabis: What You Need To Know
Access recording
A panel of trade compliance experts discuss topics such as how the cannabis industry can be more trade compliant, how to navigate the multi-jurisdictional variances in customs laws, how to reduce the risks associated with the import and export of cannabis and how to identify and mitigate sanctions risks. The session also showcases our interactive global dashboard, which provides an overview of import and export rules in over 100 markets.

Clinical Trials

Conducting clinical trials in Australia
Access recording
In partnership with Austrade, Bellberry and IQVIA, the webinar explores how to conduct clinical trials in Australia, including the benefits, process, due diligence issues and how to apply for an R&D tax incentive.

A similar webinar geared towards Chinese and Korean companies conducting or are interested to conduct clinical trials in Australia is also available.
Access the sessions: China webinar (in Mandarin) | Korea webinar (English)

Compliance Issues

Compliance issues arising out of global clinical trials
Access recording
The session explores a case study on compliance issues arising out of global clinical trials such as local regulatory and compliance issues, FDA regulatory issues, FCPA and anti-bribery issues, and M&A red flags.

17th Annual Healthcare Industry Legal & Compliance Forum - Life sciences product lifecycle in the digital age: Spotlight on certain legal and compliance aspects
Access recording
With two case studies in the background, the session explores the key considerations in the product lifecycle in a digital age for the healthcare and life sciences industry, focusing on the development and launch phases: virtual clinical trials and digital marketing of products.

Digital Transformation

Tech Talk Silicon Valley 2021: HealthTech – Key Trends
Access recording
A panel of experts provide their insights on risk management, including how regulation can dovetail with the monetization of HealthTech transactions and activities.

Tech Talk Latin America 2021: The Impact of the Global Geopolitical Climate on the Protection and Enforcement of Trade Secrets in the TMT and Healthcare Industry in LatAm
Access recording
Our panel of experts share their insights on the factors driving trade secrets and proprietary information at the cross-section of the technology and health, as well as the impact of the geopolitical climate.

Asia Pacific digital transformation in healthcare and life sciences
Access recording
Our regional experts cover the legal and regulatory implications across the full product life cycle such as R&D, collaboration and licensing, telemedicine, product launch and promotions, as well as product liability and risk management in case of an adverse event.

Disputes

Future of Disputes: Healthcare and Life Sciences
Access recording
COVID-19 has created incredible opportunity and growth in the healthcare and life sciences industry, but it has also led to increased scrutiny and challenges relating to compliance, enforcement and litigation. The session explores a pandemic-focused, interactive case study to identify and discuss mitigation strategies for these and other challenges.

EU Medical Devices

Introduction to EU medical devices regulations
Access recording
This webinar analyzes the drivers behind the main changes of the new EU regulations for medical devices (MDR) and in vitro diagnostic medical devices (IVDR) as well as covers the impact of Brexit.

New EU data protection regulation and impact on medical devices
Access recording
The session takes a look at the General Data Protection Regulation (GDPR), the impact of Brexit on the implementation and a four-step approach "fit for GDPR."

Hot in Healthcare Series

Contact Karis Berthier and Cristina Barrobes for a copy of the recordings.

Melding health and tech with M&A: Are you buying the right tools with the right partners?
Explores how healthcare companies, technology companies and financial investors can succeed in M&A within the digital health space.

What IS hot in healthcare?
This session analyzes current and projected trends for digital health, including the challenges in introducing new technologies to the UK market and how to overcome them.

What IS hot, politically?
A look at the current political climate in terms of COVID-19 and Brexit, while exploring the UK's life sciences industry, trade negotiation position and other issues arising from the pandemic.

How hot is your data?
Looks into the legal hurdles and ethics of patient data by exploring how to build patient trust in digital health and by understanding the value of healthcare data and commercial models for data sharing.

Intellectual Property

Lessons from COVID-19: Compulsory licensing in a new world
Access recording
A region-by-region look at the evolving compulsory licensing regimes and how they are being shaped by the pandemic.

Australian patent box policy and implications for medical and biotech investors
Access recording
Experts from Austrade, Baker McKenzie and IQVIA discuss the Patent Box scheme, an Australian Government initiative designed to encourage investment in medical and biotechnology innovation.

Spotlight on trade secrets in healthcare
Access recording
Did you know that one-third of healthcare companies have suffered from trade secrets theft? What are firms doing to protect their trade secrets? This webinar provides insights on how to reduce the risk of trade secrets theft.

The Fake Drug Industry: A strategic view of global enforcement
Access recording
The session focuses on anti-counterfeiting in the pharmaceutical industry, covering comparative enforcement regimes and recent legal developments.

Licensing and collaborations

Masterclass: Partnering & Licensing
Learn more and access recording
Licensing and partnerships are key mechanisms for biotech growth amid increasing interest in rare therapy areas, new technologies, personalized medicine and an increasingly fluid deal-making environment. In our Masterclass: Partnering & Licensing during the LSX Investival Showcase 2021, our presenters shared their insights on how biotech companies can navigate these issues and find the right fit for the future.

M&A

A Buyer's Guide to M&A in Latin America: A focus on healthcare
Access recording
The webinar provides insights on the healthcare M&A outlook in the region, getting deals done in the current economic context and regulatory, compliance and due diligence tips.

Tax

Preparing for  international tax reform (BEPS 2.0) from the perspective of healthcare companies (hosted by Lexology)
Contact Cristina Barrobes and Jettie Groot for a copy of the recording.
Focuses on the potential tax implications for pharmaceutical and medical technology companies of the OECD's blueprints for Pillar One and Pillar Two of the BEPS project. The second half of the webinar features a panel with tax directors from the industry on their thoughts on how they see BEPS 2.0 changing the role of tax in shaping the business models of the future and how tax departments can prepare for what is looming on the not-so-distant horizon.

Explore More Insight